Benjamin Edwards Inc Novartis Ag Transaction History

Benjamin Edwards Inc

  • $8.36 Billion
  • Q3 2025

A detailed history of Benjamin Edwards Inc transactions in Novartis Ag stock. As of the latest transaction made, Benjamin Edwards Inc holds 4,890 shares of NVS stock, worth $643,279. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,890
Previous 4,300 13.72%
Holding current value
$643,279
Previous $520,000 20.58%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 23, 2025
BUY
$113.5 - $129.73 $66,965 - $76,540
590 Added 13.72%
4,890 $627,000
Q2 2025

Aug 14, 2025
BUY
$101.96 - $121.01 $21,003 - $24,928
206 Added 5.03%
4,300 $520,000
Q1 2025

May 12, 2025
SELL
$97.14 - $115.57 $3.19 Million - $3.8 Million
-32,839 Reduced 88.92%
4,094 $456,000
Q4 2024

Feb 14, 2025
SELL
$96.78 - $117.18 $828,243 - $1 Million
-8,558 Reduced 18.81%
36,933 $3.59 Million
Q3 2024

Nov 14, 2024
BUY
$106.13 - $120.89 $2.29 Million - $2.61 Million
21,561 Added 90.1%
45,491 $5.23 Million
Q2 2024

Aug 12, 2024
BUY
$92.57 - $107.37 $17,958 - $20,829
194 Added 0.82%
23,930 $2.55 Million
Q1 2024

Apr 29, 2024
BUY
$95.27 - $108.47 $64,974 - $73,976
682 Added 2.96%
23,736 $2.3 Million
Q4 2023

Feb 06, 2024
SELL
$92.27 - $101.54 $374,062 - $411,643
-4,054 Reduced 14.95%
23,054 $2.33 Million
Q3 2023

Nov 13, 2023
BUY
$94.73 - $105.13 $315,829 - $350,503
3,334 Added 14.02%
27,108 $2.76 Million
Q2 2023

Aug 15, 2023
BUY
$92.52 - $104.91 $345,099 - $391,314
3,730 Added 18.61%
23,774 $2.4 Million
Q1 2023

Apr 27, 2023
BUY
$80.03 - $92.81 $158,619 - $183,949
1,982 Added 10.97%
20,044 $1.84 Million
Q4 2022

Feb 07, 2023
BUY
$75.55 - $92.52 $168,627 - $206,504
2,232 Added 14.1%
18,062 $1.64 Million
Q3 2022

Oct 28, 2022
SELL
$74.61 - $87.26 $67,820 - $79,319
-909 Reduced 5.43%
15,830 $1.2 Million
Q2 2022

Aug 12, 2022
SELL
$80.52 - $93.75 $36,636 - $42,656
-455 Reduced 2.65%
16,739 $1.42 Million
Q1 2022

May 04, 2022
BUY
$80.11 - $90.62 $445,491 - $503,937
5,561 Added 47.8%
17,194 $1.51 Million
Q4 2021

Feb 07, 2022
BUY
$79.7 - $88.13 $886,742 - $980,534
11,126 Added 2194.48%
11,633 $1.02 Million
Q3 2021

Nov 02, 2021
BUY
$81.78 - $95.14 $25,106 - $29,207
307 Added 153.5%
507 $41,000
Q1 2019

May 15, 2019
BUY
$75.32 - $86.15 $15,063 - $17,230
200 New
200 $19,000

Others Institutions Holding NVS

# of Institutions
1,599
Shares Held
137M
Call Options Held
1.53M
Put Options Held
2.22M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $283B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Benjamin Edwards Inc Portfolio

Follow Benjamin Edwards Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benjamin Edwards Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email